Canada: SEC Wins Novel 'Shadow Trading' Trial Against Biopharma Executive - Osler, Hoskin & Harcourt LLP

On April 5, 2024, the U.S. Securities and Exchange Commission (SEC) succeeded in its much-watched civil action against Matthew Panuwat, a former business...